ForeverLabs
0%
ClinicalClinical TrialsGeneral

Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review

Science Direct

Key Findings

Overview of MSC therapy for multiple clinical trials, showing broad potential for the clinical use of hMSCs with no reported serious adverse events..

AI generated image for: Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review

Overview of MSC therapy for multiple clinical trials, showing broad potential for the clinical use of hMSCs with no reported serious adverse events.

Ready to learn more?

Subscribe to our newsletter and book your free, 15-minute consultation with Forever Labs today.

Research Details

Source

Science Direct

Publication Date
Categories & Tags
ClinicalClinical TrialsGeneral
View Original Publication

Cite this article: Science Direct. "Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review". Published August 11, 2025. Available at: https://www.sciencedirect.com/science/article/pii/S018844092030638X

Access Original Research

View the complete study and detailed methodology from the original source.

Read Full Study↗
← All Articles← Clinical Articles

You Might Also Like

Explore more articles in this category

AI generated image for: Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial
1 min

Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial

This phase II randomized trial demonstrates that autologous hematopoietic stem cell transplantation (AHSCT) is significantly more effective than mitoxantrone at reducing MRI-detected disease activity in patients with aggressive multiple sclerosis. Results showed a 79% reduction in new T2 lesions and a significant decrease in relapse rates, supporting the need for larger phase III clinical trials.

Neurology
AI generated image for: Effect of aging on stem cells
1 min

Effect of aging on stem cells

As we age, stem cells lose efficacy and ability to heal.

NIH
AI generated image for: Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease
1 min

Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer's disease

Intravenous transplantation of bone marrow-derived mononuclear cells (BMMCs) successfully improved cognitive function and prevented neurodegeneration in two different Alzheimer's disease mouse models.

PubMed